Comparison of the effects of liraglutide and radio frequency cavitaion on abdominal obesityof the effects of liraglutide and radio frequency cavitaion on abdominal obesity

A Randomized Clinical Trial Comparing the Efficacy of Liraglutide and Radiofrequency Cavitation in the Management of Abdominal Obesity.

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20150706023084N30

Enrollment

Registered

2026-05-19

Start date

2025-11-06

Completion date

Unknown

Last updated

2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obesity. Obesity, unspecified

Interventions

Intervention 1: The intervention group consisted of 32 participants who underwent radiofrequency cavitation therapy over a period of 3 months. The treatment was performed at the Obesity and Physiother

Eligibility

Sex/Gender

All

Age

35 Years to 70 Years

Inclusion criteria

Inclusion criteria: All individuals without specific medical conditions, aged betweem 35 and 70 years Obese and have a body mass index(BMI) higher than 27

Exclusion criteria

Exclusion criteria: Pregnancy Drug abuse Obesity due to specific endocrine disorders Alcohol use Specific diseases such as cancer

Design outcomes

Primary

Measure	Time frame
Abdominal measurement. Timepoint: Three months. Method of measurement: By measuring tape.	—

Countries

Iran (Islamic Republic of)

Contacts

Public Contact??Alireza Arefzade

Islamic Azad University

Alireza.arefzadeh@iautmu.ac.ir+98 21 4486 7262

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Jun 11, 2026